Clinical Trial Update: Pre-Release VIVITROL for Opioid Dependent Inmates [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating VIVITROL for opioid dependence. The study conducted at Rhode Island Hospital has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: Rhode Island Hospital | Conditions: Substance-Related Disorders | Phase 4 | Status: COMPLETED